[Federal Register Volume 62, Number 38 (Wednesday, February 26, 1997)]
[Notices]
[Page 8746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-4735]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health (NIH)
Notice of a Meeting of the Office of AIDS Research Advisory
Council
Pursuant to Public Law 92-463, notice is hereby given of the Fourth
meeting of the Office of AIDS Research Advisory Council (OARAC) on
Friday, March 14, 1997, at the National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, Sixth Floor, Conference Room 6.
The meeting will be open to the public from 8:30 am to 3:30 pm.
The Office of AIDS Research is responsible for the planning,
coordination, and evaluation of the NIH AIDS research program. The
OARAC was established to advise the Director of the OAR regarding these
activities.
The agenda of the open meeting will include: The FY 1998 budget
request for NIH AIDS research; presentation of the NIH Implementation
Plan in response to the Report of the NIH AIDS Research Program
Evaluation Task Force; an update on the NIH Panel to Define Principles
of Therapy of HIV Infection; an update on the Prevention Science
Working Group; and presentations regarding the new initiatives in AIDS
vaccine research.
In accordance with the provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C. and section 10(d) of the Federal Advisory
Committee Act, Public Law 92-463, the meeting will be closed to the
public from 3:45 p.m. until adjournment for discussions of which the
premature disclosure could impede implementation of recommendations.
Copies of the meeting agenda and the roster of council members will
be furnished upon request by Jeannette R. De Lawter, Program Analyst,
Office of AIDS Research, National Institutes of Health, Building 31,
Room 4B54, 9000 Rockville Pike, Bethesda, MD 20892, Phone (301) 402-
3357, Fax (301) 402-3360. Any individual who requires special
assistance, such as sign language interpretation or other reasonable
accommodations, should contact Mrs. De Lawter no later than March 6.
Dated: February 21, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-4735 Filed 2-25-97; 8:45 am]
BILLING CODE 4140-01-M
